1. Introduction {#s0005}
===============

HFE-associated hereditary hemochromatosis (HH) is a common autosomal disease characterized by excessive intestinal absorption of dietary iron and its accumulation in tissues, with secondary organ damage ascribed to oxidative stress [@bib1]. The liver, being the main body iron reservoir, is particularly exposed to iron toxicity [@bib2]. Thus, HH patients have increased risk of hepatic fibrosis, cirrhosis and hepatocellular carcinoma, with symptoms often starting in the fourth decade of life [@bib1]. While most HH patients are homozygous for the p.C282Y variant of the *HFE* gene, there is great phenotypic variability among C282Y homozygotes concerning both the degree of iron loading and the risk of liver disease [@bib3], [@bib4]. Organ disease develops only in a minority of C282Y homozygotes, most commonly as a result of alcohol toxicity, obesity-related steatosis, diabetes but also due to other genetic/environmental modifying factors that are still unidentified [@bib1], [@bib3], [@bib4], [@bib5], [@bib6], [@bib7]. The *Hfe*^-/-^ mouse develops spontaneous parenchymal iron overload similar to human HH [@bib8]. Despite the increasing hepatic iron overload, *Hfe*^-/-^ mice present no hepatic fibrosis or cirrhosis [@bib9], [@bib10], which suggests the existence of efficient adaptive mechanisms that protect mice from the noxious effect of iron overload.

The transcription factor NRF2 (*Nfe2l2*/*Nrf2*) plays a key role in the adaptation to oxidative/electrophilic stress by regulating the transcriptional induction of a series of cytoprotective genes including antioxidant and xenobiotic conjugating enzymes, ubiquitin/proteasomes, chaperones and heat-shock proteins [@bib11]. Several studies have demonstrated that livers of *Nrf2*^-/-^ mice are more susceptible to oxidative/electrophilic stress than those of wild-type mice [@bib12], [@bib13], and NRF2 is increasingly regarded as an important modifier of chronic liver diseases [@bib14]. Recently, we have reported that iron activates NRF2 in mouse hepatocytes and that NRF2 is important for the viability of hepatocytes during exposure to acute dietary iron overload [@bib15]. To test the hypothesis that NRF2-mediated resistance to oxidative/electrophilic stress may be a modifier of disease progression in HFE-HH, we aimed to evaluate if the genetic suppression of *Nrf2* would predispose the *Hfe*^-/-^ mouse to spontaneous liver damage. For that purpose, a double knockout (*Hfe*/*Nrf2*^-/-^) was generated by crossing *Hfe*^-/-^ and *Nrf2*^-/-^ mice on C57BL/6 genetic background. Since the disease has a late onset in humans, we evaluated the effect of each genotype on liver pathology and antioxidant defenses in mice at the ages of 6 (young), 12--18 (middle-aged) and 24 months (old).

2. Materials and methods {#s0010}
========================

2.1. Reagents {#s0015}
-------------

All chemicals and reagents were purchased from Sigma-Aldrich (Munich, Germany), unless otherwise stated.

2.2. Animals {#s0020}
------------

To generate *Hfe* and *Nrf2* compound homozygous mutant animals, *Hfe*-null mice [@bib8] were mated with *Nrf2*-null mice [@bib16] to generate double heterozygous mutant mice (*Hfe*^+/-^ and *Nrf2*^+/-^) on C57BL/6 genetic background. These mice were then intercrossed to generate either compound homozygous mutant mice (*Hfe*/*Nrf2*^-/-^) or ones with various other combinations of mutant and wild-type alleles. Polymerase chain reaction (PCR) analysis was performed to determine the mouse genotype. Primers are listed in [Supplementary Table 1](#s0100){ref-type="sec"}.

Animals were housed at the *Instituto de Biologia Molecular e Celular* animal facility in a temperature and light-controlled environment, with free access to standard rodent chow (4RF21 containing 480 mg/kg iron sulfate heptahydrate, Mucedola, Milan, Italy) and water. Young (6 months old), middle-aged (12--18 months old) and old (24 months old) female mice were sacrificed for tissue collection. In each genotype, the middle-aged group comprised an equal number of individuals at 12 and 18 months of age. Blood was obtained by retro-orbital bleeding under terminal anesthesia with isoflurane. Liver fragments were snap-frozen in liquid nitrogen and stored at −80 °C for subsequent RNA and antioxidant enzyme activity analysis. All animals received humane care according to the criteria outlined by the Federation of European Laboratory Animal Science Associations for the care and handling of laboratory animals (EU Directive 2010/63/EU); experimental procedures were approved by the *Instituto de Biologia Molecular e Celular* Animal Ethics Committee.

2.3. Histology and immunohistochemistry {#s0025}
---------------------------------------

Tissue samples were fixed in neutral formalin 10% and embedded in paraffin. Following deparaffinization with xylene and hydration by a passage through a grade of alcohols, 3 µm-thick sections were stained with hematoxylin-eosin, Perls' Prussian blue reaction for ferric iron and Sirius red using standard procedures. Histological iron grading was performed using the grading system of Deugnier et al. [@bib17], which takes into account the size of iron deposits, as well as their cellular and lobular location, leading to three scores: hepatocytic (ranging 0--36), sinusoidal (ranging 0--12) and portal (ranging 0--12). All slides (stained with Perls\' method) were examined by the same observer, in a blind manner (i.e. with no previous knowledge of the animals\' genotypes). Evaluation of necroinflammatory lesions (sideronecrosis) was performed according to Deugnier et al. [@bib17]. Staging of liver fibrosis was performed by an anatomic pathologist (JML) according to Kleiner et al. [@bib18], as follows: 0) none; 1) mild perisinusoidal or periportal; 2) perisinusoidal and portal/periportal; 3) bridging fibrosis; and 4) cirrhosis. The quantification of collagen type I (yellow-orange birefringence) in liver sections stained with Sirius red was performed under polarized light and expressed as the percentage of fibrotic area. Digital images of 3 different fields at ×100 magnification were analyzed using ImageJ software (available at <http://rsbweb.nih.gov/ij/index.html>) to assess the percentage of stained area compared with the total evaluated liver area.

Fragmented DNA was detected through TdT-mediated dUTP nick-end labeling (TUNEL) staining as described by Silva-Gomes *et al.*[@bib15]. For the detection of F4/80, samples were blocked with 5% bovine serum albumin and 0.05% Tween 20 in phosphate buffer and incubated with rat anti-F4/80 (Serotec, Oxford, UK), followed by goat anti-rat IgG AlexaFluor 647 (Life Technologies, Carlsblad, CA, USA). For the detection of alpha-smooth muscle actin (α-SMA), samples were permeabilized in 0.2% Triton X-100 in phosphate buffer, then subjected to antigen retrieval in microwave with citrate buffer, blocked with mouse-on-mouse blocking solution (Vector, Burlingame, CA, USA) and incubated with mouse anti-α-SMA, followed by goat anti-mouse IgG AlexaFluor488 (Life Technologies, Carlsblad, CA, USA). Cell nuclei were stained with 4′,6-diamidino-2-phenylindole. Samples were analyzed in a wide field fluorescence microscope (Zeiss AxioImager Z1, Carl Zeiss, Jena, Germany).

2.4. Transmission electron microscopy {#s0030}
-------------------------------------

Liver tissue samples were fixed and embedded in Epon as described by Silva-Gomes et al. [@bib15]. Semithin sections (approximately 0.5 µm thick), stained with toluidine blue and methylene blue, were used to search for areas of interest. Ultrathin sections, either unstained or stained with uranyl acetate and lead citrate, were evaluated by electron microscopy as described by Silva-Gomes et al. [@bib15]. Elemental analysis was performed on a JEM 1400 electron microscope (Jeol, Tokyo, Japan) fit with a Schottky field emission gun, a high-angle annular dark field detector and an X-MAX 80 mm^2^ ultrathin window energy-dispersive X-ray spectroscopy detector (Oxford Instruments, Oxford, UK). Spectra were collected from 3 distinct electron-dense and 3 distinct electron-lucent areas at a 20.2° tilt angle with a stationary electron probe in scanning transmission electron microscope mode (at an accelerating voltage of 80 kV).

2.5. Tissue iron quantification {#s0035}
-------------------------------

Non-heme iron content in tissue samples was measured as described by Silva-Gomes et al. [@bib15].

2.6. Hydroxyproline content {#s0040}
---------------------------

Liver samples (10 mg) were homogenized in ultrapure water and hydroxyproline was quantified using the Hydroxyproline assay kit (Sigma-Aldrich).

2.7. Assessment of total glutathione content and glutathione-S-transferase activity {#s0045}
-----------------------------------------------------------------------------------

Liver samples were collected, homogenized in cold phosphate buffer (25 mM KH~2~PO~4~, 30 mM Na~2~HPO~4~·2H~2~O and 0.1% Triton X-100, pH 7.0) and protein content was quantified using the Bio-Rad DC protein assay kit (Hercules, CA, USA). Homogenates were centrifuged (16,000g, 10 min, 4 °C) and the supernatants were aliquoted and stored at −80 °C. Glutathione-S-transferase activity and the total glutathione content were determined as described by Assunção et al. [@bib19].

2.8. Western blotting {#s0050}
---------------------

Liver samples were homogenized in lysis buffer (300 mM sodium chloride, 50 mM Tris-HCl pH 7.4, 1% Triton X-100) containing protease inhibitors. Total protein content of lysates was measured using the RC/DC Protein Assay (Bio-Rad, Hercules, CA) and 30 µg resolved by electrophoresis on 12% SDS-polyacrylamide gels. Proteins were then transferred to 0.45 µm nitrocellulose Hybond-C Extra membranes (GE Healthcare, Portugal). After blocking with 5% dry milk in Tris-buffered saline containing 0.05% Tween 20 (TBS-T) for 1 h, membranes were incubated overnight with anti 4- hydroxynonenal rabbit antiserum clone HNE11-S (1:500; Alpha Diagnostic International, Santo Antonio, Texas, USA) or for 1 h with rabbit polyclonal antibody anti-p62 (SQSTM1) from MBL (1:1000; Nagoya, Japan), followed by a horseradish peroxidase-conjugated sheep anti-rabbit IgG (Life Technologies, Carlsblad, CA, USA) for 1 h at room temperature. After washing with TBS-T, signal was developed with a chemiluminescence substrate (Millipore, Billerica, MA, USA) and the blots exposed to CL-X Posure films (Pierce, Rockford, IL). For normalization of protein loading, blots were stripped and reprobed with a rabbit antibody against β-actin (Abcam, Cambridge, UK).

2.9. Real-time reverse-transcription-PCR {#s0055}
----------------------------------------

RNA isolation and analysis of gene expression were performed as described by Silva-Gomes et al. [@bib15]. The quantity of genes involved in iron homeostasis (hepcidin antimicrobial peptide, *Hamp*), antioxidant response \[NAD(P)H dehydrogenase, quinone 1, *Nqo1*; glutathione S-transferase, alpha 1, *Gsta1*\] and fibrogenesis (collagen, type I, alpha 1, *Col1a1*; tissue inhibitor of metalloproteinase 1, *Timp1*) was normalized against the quantity of the endogenous control gene (hypoxanthine guanine phosphoribosyl transferase, *Hprt*). Primer sequences are listed in [Supplementary Table 1](#s0100){ref-type="sec"}.

2.10. Serum parameters {#s0060}
----------------------

Serum biochemical markers of iron metabolism and liver toxicity were analyzed as described by Silva-Gomes et al. [@bib15].

2.11. Statistical analysis {#s0065}
--------------------------

All data were statistically analyzed by using the GraphPad Prism 6.07 software (GraphPad Software, CA, USA) and the averaged values are presented as mean and standard deviation. Differences among multiple group means were compared by one-way or two-way analysis of variance (when testing for mouse genotype alone or mouse genotype vs. age, respectively) with Dunnet\'s multiple comparison test. The association between variables was assessed using Pearson correlation. Statistical significance was assumed at p\<0.05.

3. Results {#s0070}
==========

*Hfe*/*Nrf2*^*+*/-^ mice gave birth to viable double knock-outs (*Hfe*/*Nrf2*^-/-^) according to Mendelian frequencies (data not shown). Young *Hfe*/*Nrf2*^-/-^ adults were apparently healthy and fertile. At 6 months of age, their average body weight was not different from age-matched wild-types or single knockouts. From middle-age on, however, they weighed significantly less than age-matched wild-types. This was in contrast with *Hfe*^-/-^ animals, which sustained gain weight until sacrifice, compared to wild-type counterparts ([Table 1](#t0005){ref-type="table"}).

Concerning the liver, *Hfe*/*Nrf2*^-/-^ animals presented a trend for lower relative liver weight, which reached statistical significance only in the middle-aged group ([Table 1](#t0005){ref-type="table"}). Serum alanine aminotransferase activity was mildly increased in old *Hfe*/*Nrf2*^-/-^ mice ([Table 1](#t0005){ref-type="table"}). Nonetheless, livers of old *Hfe*/*Nrf2*^-/-^ mice were macroscopically distinct upon dissection ([Fig. 1](#f0005){ref-type="fig"}A). Whereas wild-type and single knock-out livers displayed smooth surface with perceptible individual lobes, old *Hfe*/*Nrf2*^-/-^ livers presented an irregular surface and a contracted, distorted and nodular appearance, consistent with fibrosis. Since the activation of fibrogenesis is a major consequence of parenchymal iron overload in the livers of HFE-HH patients [@bib4], we evaluated the presence of fibrosis by quantifying the amount of hydroxyproline and the expression of pro-fibrotic genes in the liver of old mice. In line with the macroscopic features, *Hfe*/*Nrf2*^-/-^ livers contained significantly higher hydroxyproline content ([Fig. 1](#f0005){ref-type="fig"}B) and mRNA expression of *Col1a1* and *Timp1* compared with age-matched wild-types ([Figs. 1](#f0005){ref-type="fig"}C and D). Fibrosis was further assessed in paraffin-embedded liver sections of mice of all age groups using Sirius red stain. In wild-type and single knock-out livers, collagen fibers were usually restricted to the blood vessels encircling connective tissue ([Fig. 2](#f0010){ref-type="fig"}A). In *Hfe*/*Nrf2*^-/-^ livers, collagen fibers were more abundant, encompassing both periportal and pericellular fibrosis ([Fig. 2](#f0010){ref-type="fig"}A). Quantification of fibrotic area revealed that fibrosis was present in young *Hfe*/*Nrf2*^-/-^ mice, preceding the loss of body weight ([Fig. 2](#f0010){ref-type="fig"}B). The staging of fibrosis revealed its progression with ageing; the occurrence of bridging fibrosis was observed in *Hfe*/*Nrf2*^-/-^ animals at old age ([Fig. 2](#f0010){ref-type="fig"}C). Cirrhosis was not detected.

Liver fibrosis can be triggered by different stimuli and is important in several pathologies that lead to liver failure [@bib20]. To investigate whether iron was implicated in the etiopathogenesis of liver fibrosis in the present experimental model, we assessed systemic and hepatic iron overload in mice of different genotype and age groups. We found no significant differences when comparing the levels of serum iron, transferrin saturation or liver non-heme iron of *Nrf2*^-/-^ mice with those of age-matched wild-types ([Figs. 3](#f0015){ref-type="fig"}A--C). As observed in untreated HH patients, serum iron ([Fig. 3](#f0015){ref-type="fig"}A) and transferrin saturation ([Fig. 3](#f0015){ref-type="fig"}B) were significantly raised in *Hfe*^-/-^ mice of all ages. Liver iron stores were also significantly higher, increasing along animal ageing ([Fig. 3](#f0015){ref-type="fig"}C). In HH, increased iron absorption is believed to be caused by insufficient hepcidin expression [@bib4]. In line with a previous report from Ahmad et al. [@bib21], the lack of HFE associated with low steady-state levels of hepatic *Hamp* mRNA expression, as expected for the amount of iron accrued in the liver ([Fig. 3](#f0015){ref-type="fig"}D). Serum iron ([Fig. 3](#f0015){ref-type="fig"}A) and transferrin saturation ([Fig. 3](#f0015){ref-type="fig"}B) were also significantly increased in young and middle-aged *Hfe*/*Nrf2*^-/-^ mice, but not in old animals. Nonetheless, *Hfe*/*Nrf2*^-/-^ mice revealed raised liver iron stores throughout life, like their *Hfe*^-/-^ siblings ([Fig. 3](#f0015){ref-type="fig"}C), possibly related to inadequate hepatic *Hamp* expression ([Fig. 3](#f0015){ref-type="fig"}D). Perls method was performed to evaluate the amount of iron in liver tissue ([Fig. 4](#f0020){ref-type="fig"}A). Histological grading revealed that in wild-type and in *Nrf2*^-/-^ mice iron was faint or absent ([Fig. 4](#f0020){ref-type="fig"}B). In *Hfe*^-/-^ mice, iron was almost restricted to the liver parenchyma ([Fig. 4](#f0020){ref-type="fig"}B), with a decreasing gradient from the periportal to the centrilobular zones ([Fig. 4](#f0020){ref-type="fig"}A). In *Hfe*/*Nrf2*^-/-^ mice, iron was detected firstly in periportal hepatocytes, but with age there was a steady iron accumulation in sinusoidal cells ([Fig. 4](#f0020){ref-type="fig"}B). From middle-age on, *Hfe*/*Nrf2*^-/-^ livers displayed mixed (parenchymal and mesenchymal) liver iron overload pattern, as observed in secondary hemosiderosis ([Fig. 4](#f0020){ref-type="fig"}A). Electron microscopy disclosed accumulation of electron-dense material, consistent with iron, within pericanalicular hepatocyte lysosomes ([Supplementary Figure 1](#s0100){ref-type="sec"}A), as reported in human HH [@bib17], but also the presence of ferritin and hemosiderin within non-hepatocyte cells ([Supplementary Figure 1](#s0100){ref-type="sec"}B), as described by others [@bib22]. Large aggregates of non- parenchymal cells rich in a granular yellow-brown pigment strongly positive with Perls method were observed ([Fig. 4](#f0020){ref-type="fig"}A). Energy-dispersive X-ray spectroscopy elemental analysis confirmed that the electron-dense granules of non-parenchymal cells were iron- and oxygen-rich, consistent with ferric oxide components of hemosiderin ([Supplementary Figure 1](#s0100){ref-type="sec"}C). By immunofluorescence, we observed that these non- parenchymal cells contained also autofluorescent material (lipofuscin-type) and displayed macrophage immunophenotype (F4/80^+^) ([Fig. 4](#f0020){ref-type="fig"}C). Hence, *Hfe*/*Nrf2*^-/-^ livers contained a significantly higher number of iron-rich macrophages than wild-types ([Fig. 4](#f0020){ref-type="fig"}D).

Liver reticuloendothelial system cells may become iron-laden through phagocytosis of erythrocytes and iron-overloaded apoptotic hepatocytes. Since we have recently reported that *Nrf2*^-/-^ hepatocytes are more susceptible to the injury of dietary iron [@bib15], we searched for evidence of hepatocellular injury in *Hfe*/*Nrf2*^-/-^ mice. Notably, we found *bonafide* necroinflammatory foci comprising histiocytes, siderophages, hepatocyte necrosis and apoptotic bodies ([Fig. 5](#f0025){ref-type="fig"}A). Discrete features of hepatocyte apoptotic cell death included cytoplasmic shrinkage and nuclear chromatin condensation and fragmentation ([Fig. 5](#f0025){ref-type="fig"}A). The frequency of the necroinflammatory foci increased with age ([Fig. 5](#f0025){ref-type="fig"}B), in parallel with the increase of TUNEL-positive hepatocytes ([Fig. 5](#f0025){ref-type="fig"}C). Remarkably, the progression of these two features with age matched the increase in the number of iron-rich macrophages ([Fig. 4](#f0020){ref-type="fig"}D) and in the percentage of fibrotic area ([Fig. 2](#f0010){ref-type="fig"}B), indicating that reticuloendothelial iron loading and fibrosis were triggered by iron-related necroinflammation (sideronecrosis). This assumption is supported, at least in part, by the analysis of liver histology. Indeed, *Hfe*/*Nrf2*^-/-^ mice displayed iron overload of non-hepatocyte cells located in the sideronecrosis foci, consistent with phagocytosis of dead hepatocytes by reticuloendothelial cells ([Figs. 6](#f0030){ref-type="fig"}A and [7](#f0035){ref-type="fig"}A). Additionally, the resolution of the necroinflammatory foci paralleled the gradual increase of collagen fibers ([Fig. 6](#f0030){ref-type="fig"}A), and collagen accumulation arose in areas of reticuloendothelial iron loading ([Fig. 6](#f0030){ref-type="fig"}B), as highlighted by the Sirius red and Perls method features. Hepatic stellate cells (HSCs) are considered the main fibrogenic cell type in the liver, and are responsible for the production of collagen and other types of extracellular matrix [@bib23]. By transmission electron microscopy, we observed the presence of activated-type HSC nearby the sideronecrosis foci ([Fig. 7](#f0035){ref-type="fig"}A), and in the proximity of aggregates of phagocytes that had engulfed leftovers of all forms of necrosis/apoptosis, including lipofuscin-containing vesicles (residual bodies), electron-dense granules consistent with hemosiderin, and cell debris ([Fig. 7](#f0035){ref-type="fig"}B). By immunofluorescence, we established the presence of well differentiated myofibroblasts (expressing alpha-smooth muscle actin, α-SMA) contiguous with collagen bundles close to the large aggregates of lipofuscin/hemosiderin-rich macrophages ([Fig. 7](#f0035){ref-type="fig"}C). To analyse quantitatively the association between sideronecrosis and fibrosis, we pooled middle-aged and old animals of all genotypes, and for each individual we plotted the percentage of fibrotic area against the hepatic non-heme iron concentration or the number of necroinflammatory foci. [Fig. 8](#f0040){ref-type="fig"}A shows that fibrosis correlated with the non-heme hepatic iron content in the pooled population (r=0.5001, p\<0.0001), but the strength of the correlation was lowered probably by the fact that *Hfe*^-/-^ mice are somehow protected from fibrosis. On the other hand, a stronger correlation was found between liver fibrosis and the number of necroinflammatory foci (r=0.8472, p\<0.0001) ([Fig. 8](#f0040){ref-type="fig"}B).

The data presented so far show that, unlike *Hfe*^-/-^ counterparts, *Hfe*/*Nrf2*^-/-^ livers displayed sideronecrosis-associated fibrosis, which cannot be attributed only to the iron loading. Hepatic iron toxicity is generally considered to be due to increased oxidative stress leading to hepatocellular death (sideronecrosis) [@bib2]. We hypothesized that the genetic disruption of *Nrf2* rendered *Hfe*/*Nrf2*^-/-^ hepatocytes more prone to iron-induced oxidative/electrophilic stress. Thus, a series of parameters associated with oxidative/electrophilic stress was evaluated in middle-aged livers. In line with our hypothesis, the mRNA expression of the prototypical NRF2 target genes *Nqo1* ([Fig. 9](#f0045){ref-type="fig"}A) and *Gsta1* ([Fig. 9](#f0045){ref-type="fig"}B), and the enzymatic activity of glutathione-S-transferase ([Fig. 9](#f0045){ref-type="fig"}C) were significantly lower in middle-aged *Nrf2*^-/-^ and *Hfe*/*Nrf2*^-/-^ mouse livers compared with age-matched wild-type animals. Levels of total glutathione, the major hepatocellular antioxidant, were also significantly lower in *Nrf2*^-/-^ and *Hfe*/*Nrf2*^-/-^ livers than in wild-type ([Fig. 9](#f0045){ref-type="fig"}D). The alterations of these antioxidant markers were expected to cause increased oxidative/electrophilic stress and cell damage. We estimated the amount of 4-hydroxy-2-nonenal (4-HNE), a cytotoxic aldehyde product of the peroxidation of polyunsaturated fatty acids that is able to diffuse across membranes and bind covalently to functional proteins [@bib24]. According to our hypothesis, higher levels of 4-HNE-protein adducts were present in liver homogenates of *Hfe*/*Nrf2*^-/-^ mice compared with wild-type counterparts ([Fig. 9](#f0045){ref-type="fig"}E). Likewise, the expression of p62/SQSTM1 protein, which is known to be increased in chronic liver diseases in response to oxidative stress and to the accumulation of toxic protein aggregates [@bib25], was significantly greater in *Hfe*/*Nrf2*^-/-^ livers ([Fig. 9](#f0045){ref-type="fig"}F). Taken together, the data presented above indicate that the accumulation of toxic oxidation products, such as 4-HNE, likely contributed to hepatocellular injury and concomitantly to liver fibrosis in the present study.

4. Discussion {#s0075}
=============

In human HH, the long-term deposition of iron in the liver can lead to organ damage, including hepatic fibrosis and cirrhosis. The development of hepatic injury in HH is highly variable and cannot be ascribed solely to the severity of iron overload. Clinical cofactors influence disease progression and genetic factors may also play a role [@bib1], [@bib3]. In rodents, the ability of iron to stimulate the progression of experimentally-induced hepatic fibrosis has been reported; alcoholic liver fibrosis is potentiated by dietary iron [@bib26] and carbon tetrachloride-induced liver fibrogenesis is exacerbated in mice fed carbonyl iron [@bib27] and in hemojuvelin knockout mice [@bib28]. Conversely, an iron-deficient diet attenuates the development of liver fibrosis after treatment of rats with thioacetamide or bile-duct ligation [@bib29]. Yet, hepatic fibrosis and cirrhosis have not been observed in the mouse models of HFE-HH [@bib9], [@bib10] and hemojuvelin-associated HH [@bib30]; this evokes the existence of efficient adaptive mechanisms that render the mouse liver able to bear the increased iron toxicity. Such unidentified mechanisms may also be implicated in the low penetrance of the HFE mutation in humans.

Transcription factor NRF2 is a master regulator of cellular detoxification responses and redox status [@bib13] that protects mice against hepatotoxin-induced fibrosis [@bib12]. We have previously reported the development of extensive hepatocyte necrosis in *Nrf2*-null mice fed an excessive amount of dietary iron [@bib15]; this occurred in the absence of fibrosis, probably because the iron overload (equivalent to the hepatic iron stores of middle-aged *Hfe*^-/-^ mice) was induced over a short period of time (2 weeks). In the present study, we used the *Hfe*^-/-^ mouse, a model of human HFE-HH that displays several features of human C282Y homozygotes: mild parenchymal iron overload with decreasing hepatocytic gradient from the periportal to centrilobular zones, consistent with increased intestinal absorption of iron [@bib17]; insufficient hepcidin production in spite of excessive iron deposition in the hepatic parenchyma [@bib31]; elevated serum iron and transferrin saturation [@bib32]; and normal alanine aminotransferase [@bib33]. We established, so far for the first time, that the genetic disruption of *Nrf2* in the *Hfe*^-/-^ mouse increased hepatocyte apoptosis/sideronecrosis, in association with foci of inflammation, and a gradual shift of iron from hepatocytes to the sinusoidal macrophages (F4/80^+^). Serum alanine aminotransferase activity was only mildly increased in *Hfe*/*Nrf2*^-/-^ mice, which fits with the possibility that mild iron overload is insufficient to cause extensive hepatocellular necrosis/apoptosis. Conversely, necroinflammatory foci of *Hfe*/*Nrf2*^-/-^ mice were set locally associated to the presence of hepatic histiocytes, which may have originated from reticuloendothelial macrophages (Kupffer cells) and/or from circulating monocytes.

Remarkably, these are well-characterized iron-related histological lesions reported in the livers of human HH patients [@bib17], where mesenchymal iron deposits are usually not observed until the liver cell iron content is high enough to cause cell necrosis [@bib1]. In middle-aged and old *Hfe*/*Nrf2*^-/-^ animals, the iron-rich macrophages aggregated to form large siderotic nodules, which were composed of hemosiderin, lipofuscin and other products of cell degeneration. Erythrocytes flooding areas of parenchymal collapse (as seen in [Fig. 5](#f0025){ref-type="fig"}A) may have further contributed to pigment deposition within hepatic histiocytes upon phagocytosis. In this etiopathogenic process, HSCs seem to evolve into myofibroblast-like cells, presumably by the release of factors such as reactive oxygen species, lipid peroxidation products and transforming growth factor beta( TGF-β) [@bib23]. α-SMA^+^ cells are known to be responsible for collagen overproduction in injured liver areas. In *Hfe*/*Nrf2*^-/-^ animals, collagen bundles were detected in the injured areas and eventually led to the establishment of hepatic fibrosis in an age-dependent manner.

The present study describes, for the first time, a mouse model of fibrosis that conveys several features reported in the pathology of human HH: etiology (chronic iron accumulation), development over months/years, hepatocellular necrosis/apoptosis, and reticuloendothelial system iron deposits [@bib17], [@bib34]. Delima et al. [@bib35] reported increased collagen deposition in the portal tracts of mice after the simultaneous disruption of *Hfe* and another major regulator of iron homeostasis, the transferrin receptor 2. Also, a recent study reported the development of hepatic fibrosis in *Hamp*^-/-^ mice fed an iron-rich diet [@bib36]. In both studies, however, the effect was attributed to the more severe hepatic iron loading when compared with single mutant animals or with animals fed standard diet, respectively. In our model, *Hfe*/*Nrf2*^-/-^ mice appeared to accumulate more liver iron than *Hfe*^-/-^ single knockouts ([Figs. 3](#f0015){ref-type="fig"}C and [4](#f0020){ref-type="fig"}B). Although the effect did not reach statistical significance, the data suggest a possible role for NRF2 in the regulation of iron homeostasis that so far has not been reported. On the other hand, serum iron and transferrin saturation were not significantly elevated in old *Hfe*/*Nrf2*^-/-^ mice, which may have possibly resulted from a number of factors related with old age, including malnutrition, reduced efficiency of iron absorption, and/or chronic inflammation [@bib37]. Nevertheless, fibrosis developed in *Hfe*/*Nrf2*^-/-^ mice with concentrations of hepatic iron that are \~16-fold below the reported threshold for the development of hepatic fibrosis in HH patients [@bib38], and was associated with focal necroinflammation. Therefore, it seems reasonable to assume, based in our study that iron accumulation (siderosis) *per se* does not predict the development of liver injury in our model of human HFE-hemochromatosis, which may also occur in HH patients; among other factors, oxidative/electrophilic stress seems to be required.

Excessive iron within hepatocytes catalyzes lipid peroxidation of cellular organelle membranes to produce reactive aldehydes such as 4- HNE, which may form aldehyde-protein adducts. Higher amounts of 4-HNE-protein adducts were previously found in the liver of rats fed an iron-rich diet [@bib39] and of HH patients [@bib40]. The accumulation of toxic oxidation products, such as HNE, may cause lysosomal, mitochondrial and microsomal dysfunction, causing hepatocyte injury or death [@bib41]. The livers of *Hfe/Nrf2*^-/-^ mice disclosed lower basal levels of *Nqo1* and *Gsta1* mRNA expression and of glutathione-S-transferase activity. NQO1 [@bib42], [@bib43] and glutathione-S-transferases [@bib44] are involved in the detoxification of reactive molecules, including reactive oxygen species and a range of harmful electrophiles produced during membrane lipid peroxidation (e.g. 4-HNE), in the cytosol, mitochondria and endoplasmic reticulum. One such mechanism is the conjugation of 4-HNE with glutathione, which can occur spontaneously or can be catalysed by glutathione-S-transferases [@bib45], [@bib46]. In *Nrf2*^-/-^ and *Hfe/Nrf2*^-/-^ livers, we have observed lower levels of both glutathione and glutathione-S-transferase activity, which may have contributed to the increased levels of 4-HNE-protein adducts and of p62/SQSTM1 protein (a surrogate for the intracellular accumulation of toxic protein aggregates) of the double-knockouts. These alterations seem to account for the increased death of *Hfe/Nrf2*^-/-^ hepatocytes observed in the present study and for the accumulation of lipofuscin-like autofluorescent storage material (ceroid) within hepatic phagocytes. Engulfment of dead bodies by Kupffer cells and HSCs increases the expression of profibrogenic factors, and persistent activation of these cells promotes the development of fibrosis [@bib47]. HNE was also reported to up-regulate the expression of pro-fibrogenic genes (e.g. *Col1a1* and *Timp1*) by hepatic stellate cell cultures [@bib48]. In this study we established that an increased susceptibility to oxidative/electrophilic stress boosts the progression from iron accumulation (siderosis) to liver fibrosis in a model of HH, and identified a genetic modifier -- the transcription factor NRF2 -- which is a novel factor that seems to play a role (so far never reported) in the iron load liver pathogenesis of HH. Our results raise the possibility that NRF2 status might be a modifier of disease progression towards iron related liver injury, and that C282Y homozygotes with compromised NRF2 signaling may be at an increased risk of developing iron-related hepatic fibrosis or cirrhosis, even with mild increase of hepatic iron.

In conclusion, we established that the genetic suppression of *Nrf2* increases the frequency of iron-related necro-inflammatory events (sideronecrosis) and liver fibrosis in a mouse model of HFE-HH, which may be due to an increased susceptibility to oxidative/electrophilic stress. A schematic diagram of the proposed role for NRF2 in limiting oxidative damage and liver injury in HH, based in our experimental model, is presented in [Fig. 10](#f0050){ref-type="fig"}.
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![**Liver macroscopy and fibrosis markers in old mice.** (A) Macroscopic appearance of livers of representative old mice demonstrating the irregular surface and the contracted, distorted and nodular appearance of the *Hfe*/*Nrf2*^-/-^ livers (Bar=1 cm). (B) Hydroxyproline content of mouse livers, N=4. (C) and (D) Expression of *Col1a1* and *Timp1* mRNA in mouse livers, N=7--9. \*, p\<0.05 vs. age-matched wild-type mice; n.s., p\>0.05 vs. age-matched wild-type mice.](gr1){#f0005}

![**Histological evaluation of liver fibrosis.** (A) Sirius red staining for collagen in paraffin-embedded liver sections. Images are representative of N=6--10. Bar=500 µm. (B) Quantification of fibrotic area in mouse livers of all ages and genotypes, N=6--10. (C) Staging of liver fibrosis in wt (circles), *Nrf2*^-/-^(squares), *Hfe*^-/-^ (triangles) and *Hfe*/*Nrf2*^-/-^ (inverted triangles) mice of all age groups. \*, p\<0.05 vs. age-matched wild-type mice; n.s., p\>0.05 vs. age-matched wild-type mice.](gr2){#f0010}

![S**ystemic and hepatic iron parameters.** (A) Serum iron and (B) Transferrin saturation, N=6--14. (C) Hepatic non-heme iron concentration, N=6--14. (D) Ratio of hepcidin mRNA expression to hepatic iron concentration, N=4--12. \*, p\<0.05 vs. age-matched wild-type mice; n.s., p\>0.05 vs. age-matched wild-type mice.](gr3){#f0015}

![**Hepatic tissue iron distribution.** (A) Perls' prussian blue stain displaying distinct hepatic iron overload in *Hfe*^-/-^ and *Hfe*/*Nrf2*^-/-^ mice of all age groups. Insets show iron overload in periportal hepatocytes. Bar=500 µm or 50 µm (insets). (B) Histological iron grading, N=6--12. (C) Immunofluorescence micrograph of a liver section from a middle-aged *Hfe*/*Nrf2*^-/-^ mouse stained for F4/80 depicting a large aggregate of macrophages (F4/80^+^ cells) containing autofluorescent material. Bar=20 µm. (D) Quantification of iron-rich macrophages in liver sections, N=5--11. \*, p\<0.05 vs. age-matched wild-type mice; n.s., p\>0.05 vs. age-matched wild-type mice.](gr4){#f0020}

![**Histological evaluation of necroinflammatory lesions.** (A) Representative necroinflammatory foci in *Hfe*/*Nrf2*^-/-^ mouse livers containing apoptotic bodies and iron pigment in histiocytes. Center left and far left, HE stain, bar=50 µm; center right, semithin section stained with methylene blue/toluidine blue, bar=20 µm; far right, electron micrograph stained with uranyl acetate/lead citrate. Bar=5 µm. Open arrows point to hepatocyte apoptotic bodies (note contracted cytoplasm and condensed and fragmented nuclear chromatin). (B) Quantification of necroinflammtory foci in liver sections, N=6--11. (C) Quantification of TUNEL-positive cells in liver sections, N=4--8. \*, p\<0.05 vs. age-matched wild-type mice; n.s., p\>0.05 vs. age-matched wild-type mice.](gr5){#f0025}

![**Histological evidence of concurrent necroinflammation, reticuloendothelial iron loading and fibrosis.** (A) HE (left), Perls (center) and Sirius red (right) stains illustrating concurrent hepatocyte sideronecrosis, iron accumulation in histiocytes and initial pericellular fibrosis, respectively, in young *Hfe*/*Nrf2*^-/-^ mice (top images). Arrows point to hepatocyte apoptotic bodies. Bottom images disclose aggregates of hemosiderin-rich non-hepatocyte cells surrounded by collagen fibers in a middle-aged *Hfe*/*Nrf2*^-/-^ mouse. Bars=50 µm. (B) Sirius red stain for fibrosis and Perls stain for siderosis in the same liver from old *Hfe*^-/-^ and *Hfe*/*Nrf2*^-/-^ mice, representative of N=6--9. Bar=200 µm.](gr6){#f0030}

![**Detection of collagen-producing cells at necroinflammatory foci.** (A) Electron micrograph of a sideronecrosis focus in a middle-aged *Hfe*/*Nrf2*^-/-^ mouse liver displaying the accumulation of products of cell degeneration within hepatic phagocytes (arrows) and the active-type hepatic stellate cells next to collagen bundles (arrowheads and inset). Bar=5 µm (Inset, 2 µm). (B) Electron micrograph showing hemosiderin (long arrow)- and lipofuscin-containing residual bodies (small arrow and inset)-rich nodule. An activated-type stellate cell (star) containing numerous small lipid droplets, expanded endoplasmic reticulum and extensive extracellular collagen bundles (arrow head) is depicted nearby a hemosiderin-rich macrophage. Bar=5 µm (Inset, 0.5 µm). (C) Micrograph depicting the presence of myofibroblasts (α-SMA^+^) surrounding a cluster of hepatic macrophages containing autofluorescent material in the liver of a middle-aged *Hfe*/*Nrf2*^-/-^ mouse. Bar=10 µm.](gr7){#f0035}

![**Correlation between necroinflammation and liver fibrosis.** (A) and (B) Correlations between the percentage of hepatic fibrosis and the liver iron stores or the number of necroinflammatory foci in pooled middle-aged and old mice of all genotypes.](gr8){#f0040}

![**Assessment of oxidative/electrophilic stress parameters in middle-aged mice.** (A) Steady-state mRNA expression of Nqo1 and (B) Gsta1 in mouse livers, N=8--9. (C) Glutathione S-transferase enzymatic activity in liver homogenates, N=9--12. (D) Total glutathione in liver homogenates, N=3--4. (E) Detection of 4-HNE protein adducts in mouse livers, N=6--8. (F) Quantification of p62 protein in mouse livers, N=3. \*, p\<0.05 vs. age-matched wild-type mice; n.s., p\>0.05 vs. age-matched wild-type mice; °, p\<0.05 vs. age-matched *Nrf2*^-/-^ and *Hfe*^-/-^ mice.](gr9){#f0045}

![**Schematic diagram of the working model proposed for NRF2 in limiting oxidative damage and liver injury in HH.** In *Hfe*^-/-^ mice, similar to human HFE-HH, low hepcidin expression resulted in increased iron absorption and its pericanalicular accumulation within hepatocytes. Macrophages remain iron-depleted. While the genetic disruption of *Nrf2 per se* had no significant impact on iron homeostasis, the combination of iron overload (*Hfe*^-/-^) and compromised antioxidant defences (*Nrf2*^-/-^) resulted in lipid peroxidation and increased number of iron-related necroinflammatory lesions (sideronecrosis). The engulfment of dead hepatocytes led to a gradual accumulation of iron within macrophages. Myofibroblasts recruited towards the injury areas synthesized substantial amounts of collagen fibers involving the liver parenchyma with increased hepatic fibrosis in an age-dependent manner. The diagram denotes the progressive nature of HFE-HH, where iron accumulation (siderosis) (1st hit) and oxidative stress (2nd hit) are both required for the development of liver injury.](gr10){#f0050}

###### 

Body weight, relative liver weight and serum ALT.

Table 1

                              Body weight                                  Relative liver weight                       Serum ALT
  --------------------- ----- -------------------------------------------- ------------------------------------------- ---------------------------------------------
  Wild-type             *N*   \(g\)                                        (%)                                         (U/L)
   Young                8     24.2±1.9                                     4.5±0.3                                     26.4±3.0
   Middle-aged          15    30.6±3.6                                     4.7±0.7                                     33.7±9.7
   Old                  9     33.3±3.6                                     4.4±0.5                                     27.0±4.0
  *Nrf2*^*-/-*^                                                                                                        
   Young                8     22.9±3.1                                     3.5±0.7[a](#tbl1fna){ref-type="table-fn"}   25.8±5.2
   Middle-aged          15    30.5±3.5                                     4.1±0.4[a](#tbl1fna){ref-type="table-fn"}   34.7±6.9
   Old                  8     29.4±5.1[a](#tbl1fna){ref-type="table-fn"}   4.0±0.5                                     32.8±6.4
  *Hfe*^*-/-*^                                                                                                         
   Young                10    24.5±1.6                                     3.9±0.4                                     25.2±3.1
   Middle-aged          14    30.8±3.5                                     4.5±0.4                                     29.8±7.4
   Old                  8     38.9±4.5[a](#tbl1fna){ref-type="table-fn"}   3.9±0.6                                     31.5±4.3
  *Hfe*/*Nrf2*^*-/-*^                                                                                                  
   Young                6     24.1±1.6                                     4.0±0.8                                     27.7±3.8
   Middle-aged          11    26.8±2.4[a](#tbl1fna){ref-type="table-fn"}   3.8±0.8[a](#tbl1fna){ref-type="table-fn"}   35.6±10.3
   Old                  9     26.5±1.6[a](#tbl1fna){ref-type="table-fn"}   3.9±0.6                                     45.3±24.5[a](#tbl1fna){ref-type="table-fn"}

p\<0.05 vs. age-matched wild-type mice. ALT, alanine aminotransferase.
